Published in J Virol on September 17, 2008
Measles Virus Hemagglutinin Protein Epitopes: The Basis of Antigenic Stability. Viruses (2016) 1.39
The matrix protein of measles virus regulates viral RNA synthesis and assembly by interacting with the nucleocapsid protein. J Virol (2009) 1.24
Functional and structural characterization of neutralizing epitopes of measles virus hemagglutinin protein. J Virol (2012) 0.96
Wild-type measles virus with the hemagglutinin protein of the edmonston vaccine strain retains wild-type tropism in macaques. J Virol (2012) 0.88
The receptor-binding site of the measles virus hemagglutinin protein itself constitutes a conserved neutralizing epitope. J Virol (2013) 0.86
Enhanced antitumor effects of an engineered measles virus Edmonston strain expressing the wild-type N, P, L genes on human renal cell carcinoma. Mol Ther (2010) 0.85
A highly attenuated measles virus vaccine strain encodes a fully functional C protein. J Virol (2009) 0.79
Contribution of matrix, fusion, hemagglutinin, and large protein genes of the CAM-70 measles virus vaccine strain to efficient growth in chicken embryonic fibroblasts. J Virol (2009) 0.77
Actin-Modulating Protein Cofilin Is Involved in the Formation of Measles Virus Ribonucleoprotein Complex at the Perinuclear Region. J Virol (2015) 0.75
Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (1991) 38.64
Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med (1954) 9.02
Rescue of measles viruses from cloned DNA. EMBO J (1995) 7.87
SLAM (CDw150) is a cellular receptor for measles virus. Nature (2000) 6.07
Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J Virol (1990) 3.60
Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides. Virology (1980) 3.53
Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol (2001) 3.27
Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J (1987) 2.67
Global measles elimination. Nat Rev Microbiol (2006) 2.21
Recovery of pathogenic measles virus from cloned cDNA. J Virol (2000) 2.19
SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol (2002) 2.09
Measles virus: cellular receptors, tropism and pathogenesis. J Gen Virol (2006) 2.04
Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res (1994) 1.89
Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation. Virology (2006) 1.80
Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity. J Virol (2005) 1.61
Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. J Gen Virol (2004) 1.59
Altered ratios of measles virus transcripts in diseased human brains. Virology (1987) 1.55
Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins. J Virol (1998) 1.50
Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-alpha/beta signaling. Virology (2007) 1.44
Dynamics of viral RNA synthesis during measles virus infection. J Virol (2005) 1.44
Transcription inhibition and other properties of matrix proteins expressed by M genes cloned from measles viruses and diseased human brain tissue. J Virol (1994) 1.42
A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism. J Virol (2007) 1.39
Measles virus circumvents the host interferon response by different actions of the C and V proteins. J Virol (2008) 1.32
Mutations in the measles virus C protein that up regulate viral RNA synthesis. Virology (2001) 1.27
A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism. J Virol (1999) 1.25
Measles virus-induced down-regulation of CD46 is associated with enhanced sensitivity to complement-mediated lysis of infected cells. Eur J Immunol (1995) 1.25
Analysis of receptor (CD46, CD150) usage by measles virus. J Gen Virol (2002) 1.23
Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently. J Virol (2006) 1.19
Regulation of interferon signaling by the C and V proteins from attenuated and wild-type strains of measles virus. Virology (2008) 1.14
Altered interaction of the matrix protein with the cytoplasmic tail of hemagglutinin modulates measles virus growth by affecting virus assembly and cell-cell fusion. J Virol (2007) 1.13
Contributions of matrix and large protein genes of the measles virus edmonston strain to growth in cultured cells as revealed by recombinant viruses. J Virol (2005) 1.12
Activity of polymerase proteins of vaccine and wild-type measles virus strains in a minigenome replication assay. J Virol (2002) 1.04
Identification of naturally occurring amino acid variations that affect the ability of the measles virus C protein to regulate genome replication and transcription. Virology (2005) 1.02
Measles virus infection of SLAM (CD150) knockin mice reproduces tropism and immunosuppression in human infection. J Virol (2006) 1.02
The genome nucleotide sequence of a contemporary wild strain of measles virus and its comparison with the classical Edmonston strain genome. Virology (1999) 0.98
Rescue system for measles virus from cloned cDNA driven by vaccinia virus Lister vaccine strain. J Virol Methods (2006) 0.96
Genetic changes that affect the virulence of measles virus in a rhesus macaque model. Virology (2007) 0.88
Role of V protein RNA binding in inhibition of measles virus minigenome replication. Virology (2006) 0.88
Inhibition of measles virus minireplicon-encoded reporter gene expression by V protein. Virology (2006) 0.84
The genomic termini of wild-type and vaccine strains of measles virus. Virus Res (2006) 0.82
Study of the genetic stability of measles virus CAM-70 vaccine strain after serial passages in chicken embryo fibroblasts primary cultures. Virus Genes (2007) 0.80
Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc Natl Acad Sci U S A (2007) 2.56
Rescue and propagation of fully retargeted oncolytic measles viruses. Nat Biotechnol (2005) 2.40
Mitofusin 2 inhibits mitochondrial antiviral signaling. Sci Signal (2009) 2.25
High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. Cancer Res (2004) 2.14
Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog (2007) 2.09
SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol (2002) 2.09
Measles virus: cellular receptors, tropism and pathogenesis. J Gen Virol (2006) 2.04
Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM. Nat Struct Mol Biol (2011) 1.85
Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer. Breast Cancer Res Treat (2002) 1.69
SAP regulation of follicular helper CD4 T cell development and humoral immunity is independent of SLAM and Fyn kinase. J Immunol (2007) 1.68
Efficient isolation of wild strains of canine distemper virus in Vero cells expressing canine SLAM (CD150) and their adaptability to marmoset B95a cells. J Virol (2003) 1.66
Genetic evidence linking SAP, the X-linked lymphoproliferative gene product, to Src-related kinase FynT in T(H)2 cytokine regulation. Immunity (2004) 1.63
Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin. J Virol (2008) 1.62
Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity. J Virol (2005) 1.61
Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. J Gen Virol (2004) 1.59
Activation of PI3K/Akt signaling and hormone resistance in breast cancer. Breast Cancer (2006) 1.57
Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology (2006) 1.53
Cooperation between different RNA virus genomes produces a new phenotype. Nat Commun (2012) 1.53
The use of a tropism-modified measles virus in folate receptor-targeted virotherapy of ovarian cancer. Clin Cancer Res (2006) 1.50
Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling. Sci Signal (2011) 1.50
A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors. Int J Clin Oncol (2005) 1.42
Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity. Cancer Res (2006) 1.40
A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism. J Virol (2007) 1.39
Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2. J Virol (2008) 1.37
Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone. J Neurochem (2007) 1.34
Measles virus circumvents the host interferon response by different actions of the C and V proteins. J Virol (2008) 1.32
Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas. Mol Ther (2007) 1.32
Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer. Breast Cancer (2009) 1.30
Dynamic interaction of the measles virus hemagglutinin with its receptor signaling lymphocytic activation molecule (SLAM, CD150). J Biol Chem (2008) 1.29
Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus. J Virol (2006) 1.28
Outer membrane vesicles function as offensive weapons in host-parasite interactions. Microbes Infect (2010) 1.27
Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2. Breast Cancer (2013) 1.26
Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival. Breast Cancer Res Treat (2007) 1.25
The matrix protein of measles virus regulates viral RNA synthesis and assembly by interacting with the nucleocapsid protein. J Virol (2009) 1.24
Clinical significance of the 21-gene signature (Oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population. Cancer (2010) 1.23
Encephalomyocarditis virus viroporin 2B activates NLRP3 inflammasome. PLoS Pathog (2012) 1.22
Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer. Clin Cancer Res (2002) 1.20
Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently. J Virol (2006) 1.19
Reengineering paramyxovirus tropism. Virology (2004) 1.18
Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J Virol (2010) 1.18
Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer (2002) 1.18
Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma. Cancer Res (2012) 1.17
The association between Akt activation and resistance to hormone therapy in metastatic breast cancer. Eur J Cancer (2006) 1.16
The 3' enhancer CNS2 is a critical regulator of interleukin-4-mediated humoral immunity in follicular helper T cells. Immunity (2012) 1.14
Altered interaction of the matrix protein with the cytoplasmic tail of hemagglutinin modulates measles virus growth by affecting virus assembly and cell-cell fusion. J Virol (2007) 1.13
Contributions of matrix and large protein genes of the measles virus edmonston strain to growth in cultured cells as revealed by recombinant viruses. J Virol (2005) 1.12
Affinity thresholds for membrane fusion triggering by viral glycoproteins. J Virol (2007) 1.11
Efficient rescue of measles virus from cloned cDNA using SLAM-expressing Chinese hamster ovary cells. Virus Res (2005) 1.10
Tumor and vascular targeting of a novel oncolytic measles virus retargeted against the urokinase receptor. Cancer Res (2009) 1.09
Advanced malignant solitary fibrous tumor in pelvis responding to radiation therapy. Pathol Int (2007) 1.08
Phyllodes tumor of the breast: correlation between MR findings and histologic grade. Radiology (2006) 1.08
Measles virus V protein inhibits NLRP3 inflammasome-mediated interleukin-1β secretion. J Virol (2011) 1.06
Measles virus hemagglutinin: structural insights into cell entry and measles vaccine. Front Microbiol (2011) 1.06
The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses. J Virol (2014) 1.05
Absence of tumour necrosis factor facilitates primary and recurrent herpes simplex virus-1 infections. J Gen Virol (2004) 1.05
Prognostic value of the combination of epidermal growth factor receptor and c-erbB-2 in breast cancer. Surgery (2003) 1.02
Measles virus infection of SLAM (CD150) knockin mice reproduces tropism and immunosuppression in human infection. J Virol (2006) 1.02
Histidine at position 61 and its adjacent amino acid residues are critical for the ability of SLAM (CD150) to act as a cellular receptor for measles virus. J Gen Virol (2003) 1.02
Epithelial-mesenchymal transition abolishes the susceptibility of polarized epithelial cell lines to measles virus. J Biol Chem (2010) 1.01
Entry of Porphyromonas gingivalis outer membrane vesicles into epithelial cells causes cellular functional impairment. Infect Immun (2009) 1.01
Efficacy of temozolomide is correlated with 1p loss and methylation of the deoxyribonucleic acid repair gene MGMT in malignant gliomas. Neurol Med Chir (Tokyo) (2007) 1.00
The morbillivirus receptor SLAM (CD150). Microbiol Immunol (2002) 0.99
Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection. Proc Natl Acad Sci U S A (2013) 0.99
Restriction of measles virus RNA synthesis by a mouse host cell line: trans-complementation by polymerase components or a human cellular factor(s). J Virol (2002) 0.98
Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients. Int J Oncol (2005) 0.98
Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells. Eur J Cancer (2010) 0.98
Exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor CD46 on human cells for microcell-mediated chromosome transfer. BMC Biotechnol (2010) 0.97
Generation of measles virus with a segmented RNA genome. J Virol (2006) 0.97
Concurrent overexpression of Ets-1 and c-Met correlates with a phenotype of high cellular motility in human esophageal cancer. Int J Cancer (2002) 0.97
F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner. J Clin Invest (2015) 0.97
Prognostic value of c-erbB2 expression in breast cancer. J Surg Oncol (2002) 0.97
Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients. Int J Oncol (2011) 0.96
Intervertebral disc cells produce tumor necrosis factor alpha, interleukin-1beta, and monocyte chemoattractant protein-1 immediately after herniation: an experimental study using a new hernia model. Spine (Phila Pa 1976) (2005) 0.96
Rescue system for measles virus from cloned cDNA driven by vaccinia virus Lister vaccine strain. J Virol Methods (2006) 0.96
Wild-Type Measles Virus is Intrinsically Dual-Tropic. Front Microbiol (2012) 0.95
Studies on oxidopyrylium [5+2] cycloadditions: toward a general synthetic route to the C12-hydroxydaphnetoxins. Org Lett (2006) 0.94
Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells. Biochem Biophys Res Commun (2009) 0.94